跳至主要内容
临床试验/NCT05919550
NCT05919550已完成不适用

Clozapine-associated Infection

University Hospital, Caen1 个研究点 分布在 1 个国家目标入组 26,815,616 人开始时间: 2023年4月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
26,815,616
试验地点
1
主要终点
Correlation between clozapine and hinfections using a disproportionality analysis in Individual Case Reports involving at least one liable antipsychotic drug in Vigibase®

研究概览

简要总结

perform a study in VigiBase® to assess if clozapine was associated with an over-reporting of infections and to characterize those infections. The investigators also decided to assess the dose dependency associated with those infections.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Case reported in the World Health Organization (WHO) database of individual safety case reports to 11/04/2023
  • Adverse events reported were including the MedDRA terms: infections (SOC)

排除标准

  • Chronology not compatible between the drug and the toxicity

研究组 & 干预措施

Patients presenting a possible drug-induced adverse effects

干预措施: search for a clozapine intake (Drug)

结局指标

主要结局

Correlation between clozapine and hinfections using a disproportionality analysis in Individual Case Reports involving at least one liable antipsychotic drug in Vigibase®

时间窗: from the 01/01/1963 to the 11/04/2023

次要结局

  • investigate a potential dose-dependent effect(from the 01/01/1963 to the 11/04/2023)
  • Description of the clinical features of clozapine-related infections(from the 01/01/1963 to the 11/04/2023)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验